Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Histórico de Dividendos CDTX
Análise de Dividendos CDTX
Max Ratio
–Crescimento de dividendos em 5 anos
–Crescimento contínuo
–Taxa de pagamento em média de 5 anos
–
Cidara Therapeutics Inc
CDTXCidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California. Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
Verifique sua ideia de investimento
Encontre o melhor para superar o mercado
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
Preço Alvo de Wall Street
42.00 USDRácio P/E
–Rendimento de dividendos
–Relatório CDTX
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premium| Resultados | 2019 | Dinâmica |
BeatStart